Impact of Screening Patients With HIV for Kidney Disease
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. This study looks at the effect of this new screening program. Our Hypothesis is that screening for kidney disease is a cost effective and important addition to the care of patients with HIV.
| Condition |
|---|
|
HIV Infections Renal Insufficiency, Chronic Proteinuria |
| Study Type: | Observational |
| Official Title: | Impact of Screening Patients With HIV for Kidney Disease |
| Estimated Enrollment: | 1400 |
| Study Start Date: | October 2005 |
| Estimated Study Completion Date: | October 2006 |
| Estimated Primary Completion Date: | October 2006 (Final data collection date for primary outcome measure) |
The Infectious Disease Society of America has recently recommended that patients with Human Immunodeficiency Virus (HIV) be screened for kidney disease on a regular basis. Screening involves non-invasive urine and blood test and a screening program has already been initiated here in the University of Mississippi HIV clinic. However nobody knows for sure whether this will help doctors take better care of patient with HIV.
This study looks at the effect of this new screening program. We want to see how frequently abnormalities are seen on screening, how frequently certain kidney diseases are diagnosed, how often patients are referred to a nephrologist and how often a patient's management is changed by the screening. We will also estimate the cost-benefit ratio of the screening. We will review patient charts to determine what has happened in each case where screening was conducted.
This study will not involve any additional testing.
The benefit of this study will be improving our understanding of kidney disease in HIV. It will help us determine the value of screening for kidney disease and the frequency of certain kidney diseases in HIV in our clinic population.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult patients with HIV who are seen by the University of Mississippi Infectious disease clinic at the Jackson Medical Mall or patient seen at the University of Mississippi Nephrology Clinic.
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00392132
| United States, Mississippi | |
| University of Mississippi Medical Center | |
| Jackson, Mississippi, United States, 39216-4505 | |
| Principal Investigator: | Darren W Schmidt, MD | University of Mississippi Medical Center |
More Information
No publications provided
| Responsible Party: | Darren Schmidt, Assistant Professor of Medicine, University of Mississippi Medical Center |
| ClinicalTrials.gov Identifier: | NCT00392132 History of Changes |
| Other Study ID Numbers: | UMMC - HIV and CKD |
| Study First Received: | October 23, 2006 |
| Last Updated: | November 24, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Mississippi Medical Center:
|
HIV |
Additional relevant MeSH terms:
|
Renal Insufficiency Renal Insufficiency, Chronic Kidney Diseases Urologic Diseases |
ClinicalTrials.gov processed this record on March 03, 2015